Advanced search
Publication Cover
British Journal of Neurosurgery Volume 19, 2005 - Issue 1
Submit an article Journal homepage
572
Views
207
CrossRef citations to date
0
Altmetric
Consensus Statement

Management of the patient and family with neurofibromatosis 2: a consensus conference statement

DGR Evans Department of Medical Genetics, St Mary's Hospital, Manchester, UKCorrespondence[email protected]
,
ME Baser Los Angeles, CA, USA
,
B O'Reilly Department of Otolaryngology, Southern General Hospital, Glasgow, UK
,
J Rowe Centre for Sterotactic Radiosurgery, Royal Hallamshire Hospital, Sheffield, UK
,
M Gleeson Department of Otolaryngology, Guy's Hospital, London, UK
,
S Saeed Department of Otolaryngology, Manchester Royal Infirmary, Manchester, UK
,
A King Department of Neurosurgery, Hope Hospital, Manchester, UK
,
SM Huson Department of Medical Genetics, Churchill Hospital, Oxford, UK
,
R Kerr Department of Neurosurgery, John Radcliffe Hospital, Oxford, UK
,
N Thomas Department of Neurosurgery, Guy's Hospital, London, UK
,
R Irving Department of Otolaryngology, Selly Oak Hospital, Birmingham, UK
,
R MacFarlane Department of Neurosurgery, Addenbrookes Hospital, Cambridge, UK
,
R Ferner Department of Neurology, Guy's Hospital, London, UK
,
R McLeod Department of Medical Genetics, St Mary's Hospital, Manchester, UK
,
D Moffat Department of Otolaryngology, Addenbrookes Hospital, Cambridge, UK
&
R Ramsden Department of Otolaryngology, Manchester Royal Infirmary, Manchester, UK
 show all
Pages 5-12 | Received 23 Jun 2004, Accepted 02 Dec 2004, Published online: 06 Jul 2009

Citations (207)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Jane Halliday, Scott A. Rutherford, Martin G. McCabe & Dafydd G. Evans. (2018) An update on the diagnosis and treatment of vestibular schwannoma. Expert Review of Neurotherapeutics 18:1, pages 29-39.
Read now
Martin G McCabe & Dafydd Gareth Evans. (2015) Pathogenesis and management of type 2 neurofibromatosis. Expert Opinion on Orphan Drugs 3:3, pages 281-292.
Read now
Catherine E. Gilkes & D. Gareth Evans. (2014) Review of radiation therapy services for neurofibromatosis (NF2) patients in England. British Journal of Neurosurgery 28:1, pages 16-19.
Read now
D. A. Moffat, S. K. W. Lloyd, R. Macfarlane, R. Mannion, A. King, S. Rutherford, P. R. Axon, N. Donnelly, S. Freeman, J. R. Tysome, D. G. Evans & R. T. Ramsden. (2013) Outcome of translabyrinthine surgery for vestibular schwannoma in neurofibromatosis type 2. British Journal of Neurosurgery 27:4, pages 446-453.
Read now
Wolf Mann & Haralampos T Gouveris. (2009) Diagnosis and therapy of vestibular schwannoma. Expert Review of Neurotherapeutics 9:8, pages 1219-1232.
Read now
Mohsen Javadpour. (2009) Management of vestibular schwannomas in children: a role for adult surgeons in the paediatric world? and the merits of centralisation?. British Journal of Neurosurgery 23:3, pages 232-233.
Read now
Elizabeth A. Grant, Karmen M. Trzupek, Jacob Reiss, Kate Crow, Ludwine Messiaen & Richard G. Weleber. (2008) Combined Retinal Hamartomas Leading to the Diagnosis of Neurofibromatosis Type 2. Ophthalmic Genetics 29:3, pages 133-138.
Read now
H. Traunecker, C. Mallucci, R. Grundy, B. Pizer & F. Saran. (2008) Children's Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people. British Journal of Neurosurgery 22:1, pages 13-25.
Read now

Articles from other publishers (199)

Vagner Antonio Rodrigues Silva, Joel Lavinsky, Henrique Furlan Pauna, Melissa Ferreira Vianna, Vanessa Mazanek Santos, Cláudio Márcio Yudi Ikino, André Luiz Lopes Sampaio, Paula Tardim Lopes, Pauliana Lamounier, André Souza de Albuquerque Maranhão, Vitor Yamashiro Rocha Soares, José Fernando Polanski, Mariana Moreira de Castro Denaro, Carlos Takahiro Chone, Ricardo Ferreira Bento & Arthur Menino Castilho. (2023) Brazilian Society of Otology task force – Vestibular Schwannoma ‒ evaluation and treatment. Brazilian Journal of Otorhinolaryngology 89:6, pages 101313.
Crossref
Jay Idler, Onur Turkoglu, Kara Patek, Sean Stuart, Birce Taskin, Lalitha Sivaswamy & Amy Whitten. (2023) Neurocutaneous Disorders in Pregnancy. Obstetrical & Gynecological Survey 78:10, pages 606-619.
Crossref
M. Elbeltagy & M. Abbassy. (2023) Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease. Child's Nervous System 39:10, pages 2791-2806.
Crossref
Grace E Gregory, Abdurrahman I Islim, Cathal John Hannan, Adam P Jones, Charlotte Hammerbeck-Ward, Scott A Rutherford, Simon R Freeman, Simon Lloyd, Michel Kalamarides, Miriam J Smith, Kevin Couper, Catherine A McBain, Michael D Jenkinson, David Brough, Andrew T King, D Gareth Evans & Omar N Pathmanaban. (2023) The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis. Neuro-Oncology Advances 5:Supplement_1, pages i94-i104.
Crossref
Pawina Jiramongkolchai, Marc S. Schwartz & Rick A. Friedman. (2023) Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas. Otolaryngologic Clinics of North America 56:3, pages 533-541.
Crossref
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, Farzad Taghizadeh-Hesary, Masoud Garshasbi & Masoumeh Falah. (2023) The genetic landscape and possible therapeutics of neurofibromatosis type 2. Cancer Cell International 23:1.
Crossref
Dorothy Halliday, Beatrice Emmanouil & D. Gareth R. Evans. (2023) Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2 ‐related schwannomatosis . Clinical Genetics 103:5, pages 540-552.
Crossref
Jules P. J. Douwes, Kimberley S. Koetsier, Victor S. van Dam, Scott R. Plotkin, Frederick G. Barker, D. Bradley Welling, Jeroen C. Jansen, Erik F. Hensen & Helen A. Shih. (2023) Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series. Current Oncology 30:3, pages 3473-3483.
Crossref
Gabriel Sobczak, Wendy Marchant, Sara Misurelli, Garrold Mark Pyle, Samuel Gubbels & Joseph Roche. (2022) Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss. Annals of Otology, Rhinology & Laryngology 132:3, pages 284-293.
Crossref
D Gareth Evans, Dorothy Halliday, Rupert Obholzer, Shazia Afridi, Claire Forde, Scott A Rutherford, Charlotte Hammerbeck-Ward, Simon K Lloyd, Simon M Freeman, Omar N Pathmanaban, Owen M Thomas, Roger D Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Timothy Lavin, Chay Paterson, Gillian Whitfield, Martin G McCabe, Patrick R Axon, Jane Halliday, Samuel Mackeith, Allyson Parry, Patrick Axon, Juliette Buttimore, James Tysome, Neil Donnelly, Daniele Borsetto, James Whitworth, Anke Hensiek, Rajesh Jena, Mathew Guilfoyle, Richard Mannion, James Nicholson, Brinda Muthusamy, Amy Taylor, Richard Price, Karine Edme, Nicola Gamazo, Zebunnisa Vanat, Daniel Scoffings, Josh Scott, Sarah Jefferies, Richard Knight, Tamara Lamb, Yu Chuen Tam, Karen Foweraker, Fiona Harris, Paul Sanghera, Sara Meade, Richard Irving, Peter Monksfield, Nicola Ragge, Melanie Murrell, Julian Barwell, Martin English, Rikin Trivedi, Shazia K Afridi, Rosalie E Ferner, Rupert Obholzer, Victoria Williams, Chris Hammond, Karine Lascelles, Chris Skilbeck, Adam Shaw, Angela Swampillai, Suki Thomson, Nick Thomas, Eleni Maratos, Sinan Barazi, Rebecca Mullin, Susie Henley, Natalie Smith, Lal Carlton-Jones, Alison Baker, Mandy Myers, Terry Nunn, Charles Nduka, Raji Anup, Chris Duff, Simon R Freeman, Nicola Jarvis, Ian Kamaly-Asl, Andrew T King, Mark Kellett, John-Paul Kilday, Simon K Lloyd, Catherine McBain, Roger Laitt, Martin O’Driscoll, Martin McCabe, Mary Perry, Scott A Rutherford, Kirsty Henshaw, Stavros M Stivaros, Owen Thomas, Grace Vassallo, Charlotte L Hammerbeck-Ward, Omar N Pathmanaban, Jincy Kurian, Tim Lavin, Elaine F Harkness, Juliette Buttimore & Andrew T King. (2023) Radiation treatment of benign tumors in NF2-related-schwannomatosis: A national study of 266 irradiated patients showing a significant increase in malignancy/malignant progression. Neuro-Oncology Advances 5:1.
Crossref
Jody Filippo Capitanio & Pietro Mortini. 2023. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2. Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2 645 672 .
Michael D. Richards. 2023. Fundamentals of Pediatric Neuro-Ophthalmology. Fundamentals of Pediatric Neuro-Ophthalmology 87 91 .
Vanessa L. Merker, Pamela Knight, Heather B. Radtke, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin & Justin T. Jordan. (2022) Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists. Orphanet Journal of Rare Diseases 17:1.
Crossref
Sulaman Durrani, William Mualem, Ali Shoushtari, Karim Rizwan Nathani & Mohamad Bydon. (2022) Mapping the Landscape of Neurofibromatosis: A Bibliometric Evaluation Highlighting Our Current Understanding, Emerging Therapies, and Global Research Trends. World Neurosurgery 167, pages e1345-e1353.
Crossref
D. Sh. Polatova, A. V. Savkin, N. K. Asamedinov, R. R. Davletov, A. I. Nurzhabov & S. K. Nasirov. (2022) Clinical and molecular features of neurofibromatosis types 1 and 2: a review of the literature. Bone and soft tissue sarcomas, tumors of the skin 14:3, pages 33-41.
Crossref
Katrina A.B. GoddardKristy LeeAdam H. BuchananBradford C. PowellJessica Ezzell Hunter. (2022) Establishing the Medical Actionability of Genomic Variants. Annual Review of Genomics and Human Genetics 23:1, pages 173-192.
Crossref
Mindy X. Wang, Jonathan R. Dillman, Jeffrey Guccione, Ahmed Habiba, Marwa Maher, Serageldin Kamel, Prasad M. Panse, Corey T. Jensen & Khaled M. Elsayes. (2022) Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know. RadioGraphics 42:4, pages 1123-1144.
Crossref
Ryan G. Eaton & Russell R. Lonser. (2022) Familial Neoplastic Syndromes. Neurologic Clinics 40:2, pages 405-420.
Crossref
A.A. Vashkevich, A.O. Tomasheva, K.I. Raznatovskiy, A.K. Dulaev, V.V. Gvenetadze, P.A. Reztsova, V.G. Kornisheva, L.P. Kotrekhova, M.D. Gulordava & S.K. Klibson. (2022) Neurofibromatosis type 1: a clinical case. Klinicheskaya dermatologiya i venerologiya 21:6, pages 758.
Crossref
Michael Vassilyadi & Diana-Cristina Ghinda. 2022. Neurocutaneous Disorders. Neurocutaneous Disorders 483 501 .
Victor-Felix Mautner. 2022. Neurocutaneous Disorders. Neurocutaneous Disorders 281 313 .
Claire Forde, Andrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, Simon K Lloyd, Simon R Freeman, Omar N Pathmanaban, Emma Stapleton, Owen M Thomas, Roger D Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Simon Kerrigan, Miriam J Smith, Martin G McCabe, Elaine F Harkness & D Gareth Evans. (2021) Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro-Oncology 23:7, pages 1113-1124.
Crossref
Ryota Tamura. (2021) Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis. International Journal of Molecular Sciences 22:11, pages 5850.
Crossref
Daniel LewisCarmine A. DonofrioClaire O’LearyKa-loh LiXiaoping ZhuRicky WilliamsIbrahim DjoukhadarErjon AgushiCathal J. HannanEmma StapletonSimon K. LloydSimon R. FreemanAndrea WadesonScott A. RutherfordCharlotte Hammerbeck-WardD. Gareth EvansAlan JacksonOmar N. Pathmanaban, Federico RoncaroliAndrew T. King & David J. Coope. (2021) The microenvironment in sporadic and neurofibromatosis type II–related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. Journal of Neurosurgery 134:5, pages 1419-1429.
Crossref
Khodayar Goshtasbi, Mehdi Abouzari, Tyler M. Yasaka, Sina Soltanzadeh-Zarandi, Brooke Sarna, Harrison W. Lin & Hamid R. Djalilian. (2021) Treatment Analysis and Overall Survival Outcomes of Patients With Bilateral Vestibular Schwannoma. Otology & Neurotology 42:4, pages 592-597.
Crossref
Katy Phelan, R. Curtis Rogers & Luigi Boccuto. 2021. Cassidy and Allanson's Management of Genetic Syndromes. Cassidy and Allanson's Management of Genetic Syndromes 317 334 .
OlufunmilolaA Ogun. (2021) Neurofibromatosis and its Management in Nigeria: Important Neurologic and Neuro-ophthalmologic Considerations. Nigerian Journal of Ophthalmology 29:2, pages 67.
Crossref
Yin Ren, Divya A Chari, Sasa Vasilijic, D Bradley Welling & Konstantina M Stankovic. (2021) New developments in neurofibromatosis type 2 and vestibular schwannoma. Neuro-Oncology Advances 3:1.
Crossref
Jaishri Blakeley, Shannon Langmead & Peter de Blank. 2021. Neuro-Oncology for the Clinical Neurologist. Neuro-Oncology for the Clinical Neurologist 210 228 .
Yamini Attiku, Smriti Jain & Vikas Khetan. 2021. Ocular Tumors. Ocular Tumors 251 260 .
Zlatko Marušić & Eduardo Calonje. 2021. New and Emerging Entities in Dermatology and Dermatopathology. New and Emerging Entities in Dermatology and Dermatopathology 485 491 .
Robert B. Kim & Mark A. Mahan. 2021. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors 303 312 .
D. Gareth R. Evans. 2021. The Hereditary Basis of Childhood Cancer. The Hereditary Basis of Childhood Cancer 77 99 .
Anirban Das & Uri Tabori. 2021. The Hereditary Basis of Childhood Cancer. The Hereditary Basis of Childhood Cancer 23 54 .
Mohamed Elsayed, Baptiste Hochet, Renato Torres, Olivier Sterkers, Yann Nguyen, Ghizlene Lahlou & Michel Kalamarides. (2020) Metachronous Bilateral Vestibular Schwannomas. The Laryngoscope 131:1.
Crossref
Andrew B. Koo, Jacky T. Yeung, Isaac G. Freedman, Jun Hui Lee, Osama M. Ahmed, Anthony K. Ma, Danielle F. Miyagishima, Michael DiLuna & Kristopher Kahle. (2020) Clinical and economic burden of neurofibromatosis type 2 in the United States. Clinical Neurology and Neurosurgery 197, pages 106053.
Crossref
Martino Ruggieri, Agata Polizzi, Gioacchino Paolo Marceca, Stefano Catanzaro, Andrea D. Praticò & Concezio Di Rocco. (2020) Introduction to phacomatoses (neurocutaneous disorders) in childhood. Child's Nervous System 36:10, pages 2229-2268.
Crossref
Andrea Forman & Jilliane Sotelo. (2020) Tumor-Based Genetic Testing and Familial Cancer Risk. Cold Spring Harbor Perspectives in Medicine 10:8, pages a036590.
Crossref
Lucas Troude, Mohamed Boucekine, Marion Montava, Anne Balossier, Jean-Pierre Lavieille, Jean Régis & Pierre-Hugues Roche. (2019) Does NF2 status impact the results of combined surgery and adjunctive Gamma Knife surgery for large vestibular schwannomas?. Neurosurgical Review 43:4, pages 1191-1199.
Crossref
Raffaella Messina & Francesco Signorelli. 2020. Neurofibromatosis - Current Trends and Future Directions. Neurofibromatosis - Current Trends and Future Directions.
Mina Lobbous & Bruce R. Korf. 2020. Neurofibromatosis - Current Trends and Future Directions. Neurofibromatosis - Current Trends and Future Directions.
Longping Yao, Mohammed Alahmari, Yasin Temel & Koos Hovinga. (2020) Therapy of Sporadic and NF2-Related Vestibular Schwannoma. Cancers 12:4, pages 835.
Crossref
Gautam U. Mehta, Hien Huynh & Gregory P. Lekovic. (2020) Peripheral nerve sheath tumors in Neurofibromatosis Type 2: Surgical and histopathologic features. Clinical Neurology and Neurosurgery 190, pages 105649.
Crossref
Roland Goldbrunner, Michael Weller, Jean Regis, Morten Lund-Johansen, Pantelis Stavrinou, David Reuss, D Gareth Evans, Florence Lefranc, Kita Sallabanda, Andrea Falini, Patrick Axon, Olivier Sterkers, Laura Fariselli, Wolfgang Wick & Joerg-Christian Tonn. (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-Oncology 22:1, pages 31-45.
Crossref
Cathal John Hannan, Daniel Lewis, Claire O’Leary, Carmine A Donofrio, Dafydd Gareth Evans, Federico Roncaroli, David Brough, Andrew Thomas King, David Coope & Omar Nathan Pathmanaban. (2020) The inflammatory microenvironment in vestibular schwannoma. Neuro-Oncology Advances 2:1.
Crossref
Andrew Look & Russell R. Lonser. 2020. Meningiomas, Part I. Meningiomas, Part I 121 129 .
Ryota Tamura, Yukina Morimoto, Mizuto Sato, Yuki Kuranari, Yumiko Oishi, Kenzo Kosugi, Kazunari Yoshida & Masahiro Toda. (2020) Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas. Journal of Neuro-Oncology 146:2, pages 265-273.
Crossref
Isabelle Ferry, Saira Alli & James T. Rutka. 2020. Textbook of Pediatric Neurosurgery. Textbook of Pediatric Neurosurgery 1793 1834 .
Ryota Tamura, Masato Fujioka, Yukina Morimoto, Kentaro Ohara, Kenzo Kosugi, Yumiko Oishi, Mizuto Sato, Ryo Ueda, Hirokazu Fujiwara, Tetsuro Hikichi, Shinobu Noji, Naoki Oishi, Kaoru Ogawa, Yutaka Kawakami, Takayuki Ohira, Kazunari Yoshida & Masahiro Toda. (2019) A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Nature Communications 10:1.
Crossref
Cindy Chau, Remco van Doorn, Natasha M. van Poppelen, Nienke van der Stoep, Arjen R. Mensenkamp, Rolf H. Sijmons, Barbara W. van Paassen, Ans M. W. van den Ouweland, Nicole C. Naus, Annemieke H. van der Hout, Thomas P. Potjer, Fonnet E. Bleeker, Marijke R. Wevers, Liselotte P. van Hest, Marjolijn C. J. Jongmans, Marina Marinkovic, Jaco C. Bleeker, Martine J. Jager, Gregorius P. M. Luyten & Maartje Nielsen. (2019) Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers 11:8, pages 1114.
Crossref
Dorothy Halliday, Beatrice Emmanouil, Grace Vassallo, Karine Lascelles, James Nicholson, Saleel Chandratre, Geetha Anand, Martin Wasik, Pieter Pretorius, D. Gareth Evans & Allyson Parry. (2019) Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severity. Clinical Genetics 96:2, pages 151-162.
Crossref
Jose M. Anton-Rodriguez, Daniel Lewis, Ibrahim Djoukhadar, David Russell, Peter Julyan, David Coope, Andrew T. King, Simon K. L. Lloyd, D. Gareth Evans, Alan Jackson & Julian C. Matthews. (2019) [18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma. Otology & Neurotology 40:6, pages 826-835.
Crossref
Keith Kerr, Krista Qualmann, Yoshua Esquenazi, John Hagan & Dong H Kim. (2018) Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease. Neurosurgery 83:6, pages 1107-1118.
Crossref
S.K. Lloyd & D.G. Evans. (2018) Neurofibromatosis type 2 service delivery in England. Neurochirurgie 64:5, pages 375-380.
Crossref
Saikat Bhattacharjee, Preema Sinha, Arti Sarin & B.K. Prasad. (2018) A case of neurofibromatosis type 2 (NF2) with classic imaging and skin findings. Medical Journal Armed Forces India 74:4, pages 407-409.
Crossref
Ulrike Blume‐Peytavi, Helga Albrecht‐Nebe, Kathrin Hillmann & Wolfram Sterry. 2018. Atlas der Pädiatrischen Dermatologie. Atlas der Pädiatrischen Dermatologie 607 621 .
Fu Zhao, Bo Wang, Zhijun Yang, Qiangyi Zhou, Peng Li, Xingchao Wang, Jing Zhang, Junting Zhang & Pinan Liu. (2018) Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation. Journal of Neuro-Oncology 138:2, pages 417-424.
Crossref
Dai-Zhong Wang, Ping Liu, Li Yao, Ying-Hua Hao, Rui-Juan Zhu, Tao Zhang & Xian-Bin Tang. (2018) Aberrant expression of thyroid transcription factor–1 in schwannomas. Human Pathology 71, pages 84-90.
Crossref
David A. Solomon & Arie Perry. 2018. Practical Surgical Neuropathology: A Diagnostic Approach. Practical Surgical Neuropathology: A Diagnostic Approach 505 545 .
K. Fugleholm. 2018. Schädelbasischirurgie. Schädelbasischirurgie 133 160 .
Uta Schick, Hamid Borghei-Razavi, Kåre Fugleholm, Lucas Troude, Outouma Soumare, Anthony Melot, Pierre-Hugues Roche, Torstein R. Meling, Goh Inoue, Takanori Fukushima, Yoichi Nonaka, Konstantinos Barkas, Sinan Barazi, Nick Thomas, Alexander König, Sebastian Ranguis & Uwe Spetzger. 2018. Surgery of the Skull Base. Surgery of the Skull Base 91 242 .
Alberto Broniscer & Kim Nichols. 2018. Brain Tumors in Children. Brain Tumors in Children 91 116 .
Timothy D. Struve, Luke E. Pater & John Breneman. 2018. Adult CNS Radiation Oncology. Adult CNS Radiation Oncology 327 338 .
Isabelle Ferry, Saira Alli & James T. Rutka. 2018. Textbook of Pediatric Neurosurgery. Textbook of Pediatric Neurosurgery 1 55 .
Isabelle Ferry, Saira Alli & James T. Rutka. 2018. Textbook of Pediatric Neurosurgery. Textbook of Pediatric Neurosurgery 1 54 .
S.K.W. Lloyd, A.T. King, S.A. Rutherford, C.L. Hammerbeck-Ward, S.R.M. Freeman, D.J. Mawman, M. O'Driscoll & D.G. Evans. (2017) Hearing optimisation in neurofibromatosis type 2: A systematic review. Clinical Otolaryngology 42:6, pages 1329-1337.
Crossref
Kate W. GrimsrudAlyx B. Porter. (2017) Mystery Case: Widespread plexiform neurofibromas in neurofibromatosis type 1. Neurology 89:18.
Crossref
Lan Kluwe, Said Farschtschi & Victor‐F Mautner. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 9 .
A. Plana-Pla, I. Bielsa-Marsol & C. Carrato-Moñino. (2017) Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2. Actas Dermo-Sifiliográficas (English Edition) 108:7, pages 630-636.
Crossref
D. Gareth R. Evans, Hector Salvador, Vivian Y. Chang, Ayelet Erez, Stephan D. Voss, Harriet Druker, Hamish S. Scott & Uri Tabori. (2017) Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders. Clinical Cancer Research 23:12, pages e54-e61.
Crossref
Jaishri O. Blakeley, Annette Bakker, Anne Barker, Wade Clapp, Rosalie Ferner, Michael J. Fisher, Marco Giovannini, David H. Gutmann, Matthias A. Karajannis, Joseph L. Kissil, Eric Legius, Alison C. Lloyd, Roger J. Packer, Vijaya Ramesh, Vincent M. Riccardi, David A. Stevenson, Nicole J. Ullrich, Meena Upadhyaya & Anat Stemmer-Rachamimov. (2017) The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis. American Journal of Medical Genetics Part A 173:6, pages 1714-1721.
Crossref
J.M. Mesa Latorre & J.D. Garc?a D?az. (2017) C?ncer hereditario y consejo gen?tico oncol?gico. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 12:34, pages 2047-2059.
Crossref
C. Mawrin. (2017) Heredit?re Tumorsyndrome in der NeuropathologieHereditary tumor syndromes in neuropathology. Der Pathologe 38:3, pages 186-196.
Crossref
Tim Ripperger, Stefan S. Bielack, Arndt Borkhardt, Ines B. Brecht, Birgit Burkhardt, Gabriele Calaminus, Klaus-Michael Debatin, Hedwig Deubzer, Uta Dirksen, Cornelia Eckert, Angelika Eggert, Miriam Erlacher, Gudrun Fleischhack, Michael C. Frühwald, Astrid Gnekow, Gudrun Goehring, Norbert Graf, Helmut Hanenberg, Julia Hauer, Barbara Hero, Simone Hettmer, Katja von Hoff, Martin Horstmann, Juliane Hoyer, Thomas Illig, Peter Kaatsch, Roland Kappler, Kornelius Kerl, Thomas Klingebiel, Udo Kontny, Uwe Kordes, Dieter Körholz, Ewa Koscielniak, Christof M. Kramm, Michaela Kuhlen, Andreas E. Kulozik, Britta Lamottke, Ivo Leuschner, Dietmar R. Lohmann, Andrea Meinhardt, Markus Metzler, Lüder H. Meyer, Olga Moser, Michaela Nathrath, Charlotte M. Niemeyer, Rainer Nustede, Kristian W. Pajtler, Claudia Paret, Mareike Rasche, Dirk Reinhardt, Olaf Rieß, Alexandra Russo, Stefan Rutkowski, Brigitte Schlegelberger, Dominik Schneider, Reinhard Schneppenheim, Martin Schrappe, Christopher Schroeder, Dietrich von Schweinitz, Thorsten Simon, Monika Sparber-Sauer, Claudia Spix, Martin Stanulla, Doris Steinemann, Brigitte Strahm, Petra Temming, Kathrin Thomay, Andre O. von Bueren, Peter Vorwerk, Olaf Witt, Marcin Wlodarski, Willy Wössmann, Martin Zenker, Stefanie Zimmermann, Stefan M. Pfister & Christian P. Kratz. (2017) Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American Journal of Medical Genetics Part A 173:4, pages 1017-1037.
Crossref
A. Plana-Pla, I. Bielsa-Marsol & C. Carrato-Moñino. (2017) Manifestaciones cutáneas de la neurofibromatosis tipo 2: interés diagnóstico y pronóstico. Actas Dermo-Sifiliográficas.
Crossref
Hildegard Kehrer-Sawatzki, Said Farschtschi, Victor-Felix Mautner & David N. Cooper. (2016) The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis. Human Genetics 136:2, pages 129-148.
Crossref
Alexei Polishchuk, Daphne A. Haas-Kogan & Sabine Mueller. 2017. Pediatric CNS Tumors. Pediatric CNS Tumors 237 271 .
Daniel Coluccia, Adrienne Weeks, Javier Fandino, Christian Schneider, Christian Smith & James T. Rutka. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer 657 694 .
Kaleb H. Yohay & Matthew McCarthy. 2017. Common Neurosurgical Conditions in the Pediatric Practice. Common Neurosurgical Conditions in the Pediatric Practice 71 92 .
Harold ChenHarold Chen. 2017. Atlas of Genetic Diagnosis and Counseling. Atlas of Genetic Diagnosis and Counseling 2133 2142 .
Jessica Ezzell Hunter, Stephanie A. Irving, Leslie G. Biesecker, Adam Buchanan, Brian Jensen, Kristy Lee, Christa Lese Martin, Laura Milko, Kristin Muessig, Annie D. Niehaus, Julianne O’Daniel, Margaret A. Piper, Erin M. Ramos, Sheri D. Schully, Alan F. Scott, Anne Slavotinek, Nara Sobreira, Natasha Strande, Meredith Weaver, Elizabeth M. Webber, Marc S. Williams, Jonathan S. Berg, James P. Evans & Katrina A.B. Goddard. (2016) A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genetics in Medicine 18:12, pages 1258-1268.
Crossref
Brandon Birckhead, Terence T. Sio, Bruce E. Pollock, Michael J. Link & Nadia N. Laack. (2016) Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series. Journal of Neuro-Oncology 130:3, pages 553-560.
Crossref
Byung Sup Kim, Ho Jun Seol, Jung-Il Lee, Hyung Jin Shin, Kwan Park, Doo-Sik Kong, Do-Hyun Nam & Yang-Sun Cho. (2016) Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges. Neurosurgical Review 39:4, pages 643-653.
Crossref
Jaishri O. Blakeley & Scott R. Plotkin. (2016) Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro-Oncology 18:5, pages 624-638.
Crossref
. 2016. Neurocutaneous Disorders. Neurocutaneous Disorders 193 254 .
. 2016. Neurocutaneous Disorders. Neurocutaneous Disorders 3 104 .
Edward S. Tobias. 2016. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors 51 66 .
Michael C. BrodskyMichael C. Brodsky. 2016. Pediatric Neuro-Ophthalmology. Pediatric Neuro-Ophthalmology 649 776 .
Huan Li, Shu-Yu Hao, Liang Wang, Da Li, Zhen Wu, Li-Wei Zhang & Jun-Ting Zhang. (2015) Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2. Acta Neurochirurgica 157:11, pages 1983-1990.
Crossref
Maura K. Cosetti, John G. Golfinos & J. Thomas RolandJrJr. (2015) Quality of Life (QoL) Assessment in Patients with Neurofibromatosis Type 2 (NF2). Otolaryngology–Head and Neck Surgery 153:4, pages 599-605.
Crossref
Adam Hexter, Adrian Jones, Harry Joe, Laura Heap, Miriam J Smith, Andrew J Wallace, Dorothy Halliday, Allyson Parry, Amy Taylor, Lucy Raymond, Adam Shaw, Shazia Afridi, Rupert Obholzer, Patrick Axon, Andrew T King, Jan M Friedman & D Gareth R Evans. (2015) Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients. Journal of Medical Genetics 52:10, pages 699-705.
Crossref
Charlotte L. Bendon, Dominic Furniss & Henk P. Giele. (2015) Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study. Journal of Plastic, Reconstructive & Aesthetic Surgery 68:9, pages 1199-1203.
Crossref
Richard C. Allen. (2015) Proliferation and arrest. Current Opinion in Ophthalmology 26:5, pages 382-391.
Crossref
D. G. R. Evans & S. M. Stivaros. (2014) Multifocality in neurofibromatosis type 2. Neuro-Oncology 17:4, pages 481-482.
Crossref
Ramita Dewan, Alex Pemov, H. Jeffrey Kim, Keaton L. Morgan, Raul A. Vasquez, Prashant Chittiboina, Xiang Wang, Settara C. Chandrasekharappa, Abhik Ray-Chaudhury, John A. Butman, Douglas R. Stewart & Ashok R. Asthagiri. (2015) Evidence of polyclonality in neurofibromatosis type 2?associated multilobulated vestibular schwannomas. Neuro-Oncology 17:4, pages 566-573.
Crossref
David M. Thomas & Mandy L. Ballinger. (2014) Etiologic, environmental and inherited risk factors in sarcomas. Journal of Surgical Oncology 111:5, pages 490-495.
Crossref
Emmanuel J. K. Adu & Adofo Koranteng. (2015) Clinical and Therapeutic Features of Neurofibromatosis in Ghana. African Journal of Pathology and Microbiology 4, pages 1-5.
Crossref
D.G.R. Evans. 2015. Neurocutaneous Syndromes. Neurocutaneous Syndromes 87 96 .
Adam P. Ostendorf & David H. Gutmann. 2015. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease 921 933 .
Uri Tabori, Matthias A. Karajannis & John G. Pappas. 2015. Molecular Pathology of Nervous System Tumors. Molecular Pathology of Nervous System Tumors 1 22 .
Uri Tabori, Anne-Marie Laberge, Benjamin Ellezam & Anne-Sophie Carret. 2015. Pediatric Neuro-oncology. Pediatric Neuro-oncology 69 89 .
Harold ChenHarold Chen. 2014. Atlas of Genetic Diagnosis and Counseling. Atlas of Genetic Diagnosis and Counseling 1 10 .
Shibin Sun & Ali Liu. (2014) Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2. Journal of Neurosurgery 121:Suppl_2, pages 143-149.
Crossref
Nardin Samuel, Anita Villani, Conrad V. Fernandez & David Malkin. (2014) Management of familial cancer: sequencing, surveillance and society. Nature Reviews Clinical Oncology 11:12, pages 723-731.
Crossref
Jung Won Choi, Ji Yeoun Lee, Ji Hoon Phi, Kyu-Chang Wang, Hyun-Tai Chung, Sun Ha Paek, Dong Gyu Kim, Sung-Hye Park & Seung-Ki Kim. (2014) Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2. Journal of Neurosurgery: Pediatrics 13:6, pages 650-657.
Crossref
Joanna Walton, Neil P. Donnelly, Yu Chuen Tam, Ilse Joubert, Juliette Durie-Gair, Cay Jackson, Richard A. Mannion, James R. Tysome, Patrick R. Axon & Daniel J. Scoffings. (2014) MRI Without Magnet Removal in Neurofibromatosis Type 2 Patients With Cochlear and Auditory Brainstem Implants. Otology & Neurotology 35:5, pages 821-825.
Crossref
Brigitte C. Widemann, Maria T. Acosta, Sylvia Ammoun, Allan J. Belzberg, Andre Bernards, Jaishri Blakeley, Antony Bretscher, Karen Cichowski, D. Wade Clapp, Eva Dombi, Gareth D. Evans, Rosalie Ferner, Cristina Fernandez-Valle, Michael J. Fisher, Marco Giovannini, David H. Gutmann, C. Oliver Hanemann, Robert Hennigan, Susan Huson, David Ingram, Joe Kissil, Bruce R. Korf, Eric Legius, Roger J. Packer, Andrea I McClatchey, Frank McCormick, Kathryn North, Minja Pehrsson, Scott R. Plotkin, Vijaya Ramesh, Nancy Ratner, Susann Schirmer, Larry Sherman, Elizabeth Schorry, David Stevenson, Douglas R. Stewart, Nicole Ullrich, Annette C. Bakker & Helen Morrison. (2014) CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics Part A 164:3, pages 563-578.
Crossref
Rashmi Sharma, Parmod Kalsotra, Rohan Gupta, Nitika Gupta & Ghanshyamdev Gupta. (2014) Neurofibromatosis II. An International Journal of Otorhinolaryngology Clinics 6:3, pages 4-6.
Crossref
Jean-Philippe Neau, Ga?lle Godeneche, St?phane Mathis & G?rard Guillet. 2014. Neurologic Aspects of Systemic Disease Part III. Neurologic Aspects of Systemic Disease Part III 1561 1594 .
Takashi Eguchi, Keiichiro Takasuna, Atsushi Sato, Yusaku Shimizu, Yohei Hidai, Makoto Matsubara, Atsunori Shinoda, Masayuki Fujiwara, Kazuo Yoshida & Jun Amano. 2014. Tumors of the Central Nervous System, Volume 11. Tumors of the Central Nervous System, Volume 11 315 321 .
Andrew L. Lin & David H. Gutmann. (2013) Advances in the treatment of neurofibromatosis-associated tumours. Nature Reviews Clinical Oncology 10:11, pages 616-624.
Crossref
Michelle A. Holman, William R. Schmitt, Matthew L. Carlson, Colin L. W. Driscoll, Charles W. Beatty & Michael J. Link. (2013) Pediatric cerebellopontine angle and internal auditory canal tumors. Journal of Neurosurgery: Pediatrics 12:4, pages 317-324.
Crossref
Elisabeth Castellanos, Imma Rosas, Ares Solanes, Isabel Bielsa, Conxi Lázaro, Cristina Carrato, Cristina Hostalot, Pepe Prades, Francesc Roca-Ribas, Ignacio Blanco & Eduard Serra. (2012) In vitro antisense therapeutics for a deep intronic mutation causing Neurofibromatosis type 2. European Journal of Human Genetics 21:7, pages 769-773.
Crossref
Stéphane Goutagny, Alpha B. Bah, Béatrice Parfait, Olivier Sterkers & Michel Kalamarides. (2013) Neurofibromatosis type 2 in the elderly population: Clinical and molecular features. American Journal of Medical Genetics Part A 161:4, pages 667-670.
Crossref
Joanna Siwiec-Proscinska, Anna Gotz-Wieckowska, Marta Pawlak & Jaroslaw Kociecki. (2013) Epiretinal membrane and cataract in a 5-year-old boy with the suspicion of neurofibromatosis type 2. Open Medicine 8:1.
Crossref
Simon K.W. Lloyd & D. Gareth R. Evans. 2013. Peripheral Nerve Disorders. Peripheral Nerve Disorders 957 967 .
Susan M. Huson & Bruce R. Korf. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics 1 45 .
S.M. Huson. 2013. Brenner's Encyclopedia of Genetics. Brenner's Encyclopedia of Genetics 33 38 .
P. B?umer, V. F. Mautner, T. B?umer, M. U. Schuhmann, M. Tatagiba, S. Heiland, T. Kaestel, M. Bendszus & M. Pham. (2012) Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy. Journal of Neurology 260:1, pages 38-46.
Crossref
Madjid Samii & Venelin GerganovMadjid Samii & Venelin Gerganov. 2013. Surgery of Cerebellopontine Lesions. Surgery of Cerebellopontine Lesions 315 374 .
DG Evans, FL Raymond, JG Barwell & D Halliday. (2011) Genetic testing and screening of individuals at risk of NF2. Clinical Genetics 82:5, pages 416-424.
Crossref
James R. Tysome, Robert Macfarlane, Juliette Durie-Gair, Neil Donnelly, Richard Mannion, Richard Knight, Frances Harris, Zebunnisa H. Vanat, Yu Chen Tam, Katherine Burton, Anke Hensiek, F. Lucy Raymond, David A. Moffat & Patrick R. Axon. (2012) Surgical Management of Vestibular Schwannomas and Hearing Rehabilitation in Neurofibromatosis Type 2. Otology & Neurotology 33:3, pages 466-472.
Crossref
Anita Villani, David Malkin & Uri Tabori. (2011) Syndromes Predisposing to Pediatric Central Nervous System Tumors: Lessons Learned and New Promises. Current Neurology and Neuroscience Reports 12:2, pages 153-164.
Crossref
Jane W. Chan. (2012) Neuro-ophthalmic Features of the Neurocutaneous Syndromes. International Ophthalmology Clinics 52:3, pages 73-85.
Crossref
Elizabeth A. Thiele & Bruce R. Korf. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology 497 517 .
James H. Tonsgard, Bakhtiar Yamini & David M. Frim. 2012. Schmidek and Sweet Operative Neurosurgical Techniques. Schmidek and Sweet Operative Neurosurgical Techniques 581 587 .
Sarah Jost & David H. Gutmann. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II 569 582 .
Ashok R. Asthagiri, Katherine E. Warren & Russell R. Lonser. 2012. Brain Tumors. Brain Tumors 588 599 .
. 2012. Atlas of Genetic Diagnosis and Counseling. Atlas of Genetic Diagnosis and Counseling 1571 1576 .
Erik J. Uhlmann & Scott R. Plotkin. 2012. Neurodegenerative Diseases. Neurodegenerative Diseases 266 277 .
Simone L. Ardern-Holmes & Kathryn N. North. (2011) Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2. Current Treatment Options in Neurology 13:6, pages 529-543.
Crossref
Michael E Baser, Jan M Friedman, Harry Joe, Andrew Shenton, Andrew J Wallace, Richard T Ramsden & D Gareth R Evans. (2011) Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genetics in Medicine 13:6, pages 576-581.
Crossref
Yi-An Chen, Hung-Chien Lin & Sheau-Chiou Chao. (2011) Nodules on the trunk and the arm of an 8-year-old boy. Dermatologica Sinica 29:2, pages 79-80.
Crossref
Rosalie E. Ferner & Margaret J. Jackson. 2012. The Causes of Epilepsy. The Causes of Epilepsy 183 188 .
. 2012. The Causes of Epilepsy. The Causes of Epilepsy 113 624 .
G. Chick. (2011) Tumores primarios de los nervios periféricos. EMC - Aparato Locomotor 44:1, pages 1-12.
Crossref
Spyros S. Kollias, David Mark Capper, Nadja Saupe & Krisztina Baráth. 2011. Imaging of the Spine. Imaging of the Spine 305 375 .
Teresa Stachowicz-Stencel, Anna Synakiewicz, Ewa Bien, Elzbieta Adamkiewicz-Drozynska, Miroslawa Wybieralska-Dubaniewicz & Anna Balcerska. (2010) Multiple primary cranio-spinal tumours in a 13-year-old female with neurofibromatosis type 2 management strategy. Child's Nervous System 27:1, pages 175-178.
Crossref
Evelyn X. Fu & Arun D. Singh. 2011. Pediatric Retina. Pediatric Retina 159 189 .
Rosalie E. Ferner, Susan M. Huson & D. Gareth R. EvansD. Gareth R. Evans. 2011. Neurofibromatoses in Clinical Practice. Neurofibromatoses in Clinical Practice 47 70 .
Melissa A. Reyes & Daniel B. Eisen. (2010) Inherited syndromes. Dermatologic Therapy 23:6, pages 606-642.
Crossref
Kara N. Shah. (2010) The Diagnostic and Clinical Significance of Caf?-au-lait Macules. Pediatric Clinics of North America 57:5, pages 1131-1153.
Crossref
Meg R. Gerstenblith, Alisa M. Goldstein & Margaret A. Tucker. (2010) Hereditary Genodermatoses with Cancer Predisposition. Hematology/Oncology Clinics of North America 24:5, pages 885-906.
Crossref
Lan Kluwe & Victor‐F Mautner. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Marta P?rez-Grau, N?ria Mir?Jos? Prades, Juan Verg?s, Susana Lareo & Francesc Roca-Ribas. (2010) Neurofibromatosis tipo 2. Acta Otorrinolaringol?gica Espa?ola 61:4, pages 306-311.
Crossref
Manish Singh Sharma, Rakesh Singh, Shashank S. Kale, Deepak Agrawal, Bhawani Shankar Sharma & Ashok Kumar Mahapatra. (2010) Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2. Journal of Neuro-Oncology 98:2, pages 265-270.
Crossref
Omar Arnaout, Andrew Fishman, H. Hunt Batjer & Bernard R. Bendok. (2010) Neurocutaneous Disorders. Contemporary Neurosurgery 32:7, pages 1-5.
Crossref
Omar Arnaout, Andrew Fishman, H. Hunt Batjer & Bernard R. Bendok. (2010) Neurocutaneous Disorders. Contemporary Neurosurgery 32:6, pages 1-4.
Crossref
Kajetan L. von Eckardstein, Charles W. Beatty, Colin L. W. Driscoll & Michael J. Link. (2010) Spontaneous regression of vestibular schwannomas after resection of contralateral tumor in neurofibromatosis Type 2. Journal of Neurosurgery 112:1, pages 158-162.
Crossref
Marta Pérez-Grau, Núria Miró, José Prades, Juan Vergés, Susana Lareo & Francesc Roca-Ribas. (2010) Neurofibromatosis type 2. Acta Otorrinolaringologica (English Edition) 61:4, pages 306-311.
Crossref
J.M. de Campos Guti?rrez. (2010) Comentario al trabajo Neurinomas intramedulares. Presentaci?n de dos casos de un tumor infrecuente de L.M. Bernal Garc?a y cols. Neurocirug?a 21:3, pages 238-239.
Crossref
G. Chick. (2010) Tumeurs primitives des nerfs périphériques. EMC - Appareil locomoteur 5:4, pages 1-12.
Crossref
A. Varoquaux, P. Cassagneau, N. Girard, G. Plako-Parola, F. Chapon, A. Deveze & G. Moulin. 2010. Imagerie en ORL. Imagerie en ORL 367 383 .
Alp Özgün Börcek, John A. Rutka & James T. Rutka. 2010. Meningiomas. Meningiomas 593 600 .
Arie Perry. 2010. Practical Surgical Neuropathology. Practical Surgical Neuropathology 427 453 .
Jennifer E. Axilbund & Beth N. Peshkin. 2010. Handbook of Genomics and the Family. Handbook of Genomics and the Family 267 291 .
Michael C. BrodskyMichael C. Brodsky. 2010. Pediatric Neuro-Ophthalmology. Pediatric Neuro-Ophthalmology 503 596 .
DGareth R Evans. (2009) Neurofibromatosis type 2 (NF2): A clinical and molecular review. Orphanet Journal of Rare Diseases 4:1.
Crossref
Thomas P Slavin & Georgia L Wiesner. (2009) Developmental defects and childhood cancer. Current Opinion in Pediatrics 21:6, pages 717-723.
Crossref
L. Kluwe & V.-F. Mautner. (2009) Neurofibromatose Typ 2Neurofibromatosis type 2. medizinische genetik 21:4, pages 532-538.
Crossref
Eiji Ito, Kiyoshi Saito, Hiroshi Yatsuya, Tetsuya Nagatani & Goro Otsuka. (2009) Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2. Neurosurgical Review 32:4, pages 425-433.
Crossref
Katrin Scheinemann, Ute BartelsAnnie HuangCynthia Hawkins, Abhaya V. Kulkarni, Eric BouffetUri Tabori. (2009) Survival and functional outcome of childhood spinal cord low-grade gliomas. Journal of Neurosurgery: Pediatrics 4:3, pages 254-261.
Crossref
D Gareth R Evans. (2009) Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]. Genetics in Medicine 11:9, pages 599-610.
Crossref
D. Gareth Evans, Michel Kalamarides, Kim Hunter-Schaedle, Jaishri Blakeley, Jeffrey Allen, Dusica Babovic-Vuskanovic, Allan Belzberg, Gideon Bollag, Ruihong Chen, Emmanuelle DiTomaso, John Golfinos, Gordon Harris, Abraham Jacob, Ganjam Kalpana, Matthias Karajannis, Bruce Korf, Razelle Kurzrock, Meng Law, Andrea McClatchey, Roger Packer, Pamela Roehm, Allan Rubenstein, William SlatteryIIIIII, James H. Tonsgard, D. Bradley Welling, Brigitte Widemann, Kaleb Yohay & Marco Giovannini. (2009) Consensus Recommendations to Accelerate Clinical Trials for Neurofibromatosis Type 2. Clinical Cancer Research 15:16, pages 5032-5039.
Crossref
Jan Walter, Susanne A. Kuhn, Michael Brodhun, Rupert Reichart & Rolf Kalff. (2009) Pulmonary meningioma and neurinoma associated with multiple CNS tumours in a patient with neurofibromatosis type 2. Clinical Neurology and Neurosurgery 111:5, pages 454-459.
Crossref
Ashok R Asthagiri, Dilys M Parry, John A Butman, H Jeffrey Kim, Ekaterini T Tsilou, Zhengping Zhuang & Russell R Lonser. (2009) Neurofibromatosis type 2. The Lancet 373:9679, pages 1974-1986.
Crossref
Ji Hoon Phi, Dong Gyu Kim, Hyun‐Tai Chung, Joongyub Lee, Sun Ha Paek & Hee‐Won Jung. (2009) Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2. Cancer 115:2, pages 390-398.
Crossref
Chifumi Iseki, Yoshimi Takahashi, Manabu Wada, Toru Kawanami, Keiji Kurita & Takeo Kato. (2009) A case of neurofibromatosis type 2 (NF2) presenting with late-onset axonal polyneuropathy. Rinsho Shinkeigaku 49:7, pages 419-423.
Crossref
Joo Yeon KoJi Eun KimYoung Hoon KimYoung Suck Ro. (2009) Cutaneous Plexiform Schwannomas in a Patient with Neurofibromatosis Type 2. Annals of Dermatology 21:4, pages 402.
Crossref
Torbjørn Elvsåshagen, Volker Solyga, Søren Bakke, Arvid Heiberg & Emilia Kerty. (2009) Nevrofibromatose type 2 og auditorisk hjernestammeimplantat. Tidsskrift for Den norske legeforening 129:15, pages 1469-1473.
Crossref
Colin M. Parsons, Robert J. Canter & Vijay P. Khatri. (2009) Surgical Management of Neurofibromatosis. Surgical Oncology Clinics of North America 18:1, pages 175-196.
Crossref
A. Villette, M. Brun, C. Le Manh, D. Lacombe & J.-F. Chateil. (2009) Imagerie des phacomatoses chez l'enfant. EMC - Radiologie et imagerie m?dicale - Musculosquelettique - Neurologique - Maxillofaciale 4:2, pages 1-30.
Crossref
S. Goutagny, D. Bouccara, A. Bozorg-Grayeli, O. Sterkers & M. Kalamarides. (2009) Neurofibromatose de type 2. EMC - Neurologie 6:1, pages 1-11.
Crossref
S.R. Plotkin. 2009. Encyclopedia of Neuroscience. Encyclopedia of Neuroscience 419 425 .
Karen Stephens. 2009. Molecular Pathology in Clinical Practice: Genetics. Molecular Pathology in Clinical Practice: Genetics 239 246 .
Karen Stephens. 2009. Molecular Pathology in Clinical Practice: Oncology. Molecular Pathology in Clinical Practice: Oncology 77 84 .
Katharina Wimmer, Hildegard Kehrer‐Sawatzki & Eric Legius. 2008. Hereditary Tumors. Hereditary Tumors 127 145 .
S. de Ribaupierre, O. Vernet, M. Vinchon & B. Rilliet. (2008) Phacomatoses et tumeurs génétiquement déterminées : la transition enfant–adulte. Neurochirurgie 54:5, pages 642-653.
Crossref
Scott R Plotkin, Marybeth A Singh, Caroline C O'Donnell, Gordon J Harris, Andrea I McClatchey & Chris Halpin. (2008) Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nature Clinical Practice Oncology 5:8, pages 487-491.
Crossref
Y.-H. Kuo, D. Roos & B.P. Brophy. (2008) Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2. Journal of Clinical Neuroscience 15:7, pages 744-748.
Crossref
David EllisonD Ellison, A Perry, M Rosenblum, S Asa, R Reid & D Louis. 2008. Greenfield's Neuropathology Eighth Edition. 2 Volume Set and DVD. Greenfield's Neuropathology Eighth Edition. 2 Volume Set and DVD 2001 2182 .
Marianne F. James, Johanna M. Lelke, Mia MacCollin, Scott R. Plotkin, Anat O. Stemmer-Rachamimov, Vijaya Ramesh & James F. Gusella. (2008) Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. Neurobiology of Disease 29:2, pages 278-292.
Crossref
A.T.M. Rennie, L. Side, R.S.C. Kerr, P. Anslow & P. Pretorius. (2008) Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis. Clinical Radiology 63:2, pages 193-200.
Crossref
D. Gareth R. Evans, Richard T. Ramsden, Andrew Shenton, Carolyn Gokhale, Naomi Bowers, Susan M. Huson & Andrew J. Wallace. (2008) What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?. Journal of Neurosurgery 108:1, pages 92-96.
Crossref
Edward S. Tobias & J. M. Connor. 2008. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors 33 47 .
Nicole J. Ullrich. (2008) Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Developmental Disabilities Research Reviews 14:3, pages 229-237.
Crossref
Catherine Bearce Nowak. (2007) The Phakomatoses: Dermatologic Clues to Neurologic Anomalies. Seminars in Pediatric Neurology 14:3, pages 140-149.
Crossref
S. Goutagny, D. Bouccara, A. Bozorg-Grayeli, O. Sterkers & M. Kalamarides. (2007) La neurofibromatose de type 2. Revue Neurologique 163:8-9, pages 765-777.
Crossref
Jeremy Rowe, Alison Grainger, Lee Walton, Matthias Radatz & Andras Kemeny. (2007) SAFETY OF RADIOSURGERY APPLIED TO CONDITIONS WITH ABNORMAL TUMOR SUPPRESSOR GENES. Neurosurgery 60:5, pages 860-864.
Crossref
Andreas F. Hottinger & Yasmin Khakoo. (2007) Update on the management of familial central nervous system tumor syndromes. Current Neurology and Neuroscience Reports 7:3, pages 200-207.
Crossref
Rosalie E Ferner. (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. The Lancet Neurology 6:4, pages 340-351.
Crossref
David Mathieu, Douglas Kondziolka, John C. Flickinger, Ajay Niranjan, Richard Williamson, Juan J. Martin & L. Dade Lunsford. (2007) STEREOTACTIC RADIOSURGERY FOR VESTIBULAR SCHWANNOMAS IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 2. Neurosurgery 60:3, pages 460-470.
Crossref

Displaying 200 of 207 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.